These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8422565)

  • 1. The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases.
    Hollingworth P
    Br J Rheumatol; 1993 Jan; 32(1):73-7. PubMed ID: 8422565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of drugs used in juvenile arthritis.
    Skeith KJ; Jamali F
    Clin Pharmacokinet; 1991 Aug; 21(2):129-49. PubMed ID: 1884567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs in juvenile rheumatoid arthritis.
    Fujikawa S
    Acta Paediatr Jpn; 1993 Oct; 35(5):447-53. PubMed ID: 8256630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.
    Litalien C; Jacqz-Aigrain E
    Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis.
    Leak AM; Richter MR; Clemens LE; Hall MA; Ansell BM
    Clin Exp Rheumatol; 1988; 6(2):157-60. PubMed ID: 3052965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Oct; 18(4):241-77. PubMed ID: 387372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
    De Silva B; Banney L; Uttley W; Luqmani R; Schofield O
    Pediatr Dermatol; 2000; 17(6):480-3. PubMed ID: 11123786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states.
    Clissold SP; Beresford R
    Drugs; 1987 May; 33(5):478-502. PubMed ID: 3297621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiaprofenic acid. A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases and pain states.
    Sorkin EM; Brogden RN
    Drugs; 1985 Mar; 29(3):208-35. PubMed ID: 3886353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The introduction of non-steroidal antirheumatics: is there a rational therapy].
    Schlumpf U
    Schweiz Med Wochenschr; 1982 Aug; 112(35):1200-8. PubMed ID: 6753142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological management of juvenile rheumatoid arthritis.
    Rose CD; Doughty RA
    Drugs; 1992 Jun; 43(6):849-63. PubMed ID: 1379157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in NSAID therapy.
    Miller LG; Prichard JG
    Prim Care; 1990 Sep; 17(3):589-601. PubMed ID: 2236338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
    Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management.
    Brogden RN; Wiseman LR
    Drugs; 1996 Jul; 52(1):113-24. PubMed ID: 8799688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.
    Todd PA; Clissold SP
    Drugs; 1991 Apr; 41(4):625-46. PubMed ID: 1711963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the use and adverse effects of non-steroidal anti-inflammatory drugs: a pilot study].
    Perić A; Toskić-Radojicić M
    Vojnosanit Pregl; 2006 Mar; 63(3):271-7. PubMed ID: 16605193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.
    Dooley M; Spencer CM; Dunn CJ
    Drugs; 2001; 61(9):1351-78. PubMed ID: 11511027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs during the therapy of rheumatic diseases. The rheumatologist's perspective.
    Robinson DR
    Am J Med; 1988 Feb; 84(2A):1-4. PubMed ID: 3126654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.